Results 1 to 10 of about 1,949 (76)

Autoimmune polyendocrine syndrome type 2 complicated with hyperthyroidism crisis and diabetic acute complications: a case report and literature review [PDF]

open access: yes, 2023
Objective To enhance clinicians’ diagnosis and treatment capability for autoimmune polyendocrine syndrome type 2 (APS-2),and reduce missed diagnosis and misdiagnosis.
Jian Li, Wu Qinan, Zhao Qiquan, LYU Xinlu
core   +1 more source

Are psychiatric disorders associated with thyroid hormone therapy in adolescents and young adults with type 1 diabetes? 青少年和青壮年1型糖尿病患者的精神障碍与甲状腺激素治疗有关吗?

open access: yesJournal of Diabetes, Volume 13, Issue 7, Page 562-571, July 2021., 2021
Highlights Several psychiatric disorders were associated with levothyroxine therapy (LT4). Depression, anxiety disorders, and attention‐deficit/hyperactivity disorder showed the strongest relation to LT4. Thyroid autoimmunity itself (no LT4) was not associated with psychiatric disorders.
Alexander Eckert   +9 more
wiley   +1 more source

国医大师王琦从过敏体质论治斑秃经验 [PDF]

open access: yes, 2018
王琦教授基于\"体病相关论\"阐释了斑秃与过敏体质之间的密切相关性,以\"辨体-辨病-辨证\"的三辨诊疗模式为临床理论指导,不仅关注患者之病兼以调患者之体。在诊疗过程中,王琦教授先辨识患者的过敏体质,再根据斑秃的病症以及不同病程中证型的变化而灵活加减用药,调理过敏体质专用药为乌梅、蝉蜕、野生赤芝、制何首乌,四药相配,驱散风热之邪又能养阴生津,收中有散,每获良效。王教授将治病与调体相结合,既改善了患者的过敏性体质,防止斑秃复发,又针对斑秃的病情对症下药从而改善症状 ...
朱丽冰, 王济, 王琦
core   +1 more source

评论性翻译:关于1型糖尿病的临床实践指南(235-275页) [PDF]

open access: yes, 2022
Este trabajo se basa en una traducción comentada al chino occidental del texto médico Guía de práctica clínica sobre la diabetes de tipo 1. Este texto médico describe sistemáticamente la evaluación y el tratamiento de las complicaciones asociadas a la ...
He, Mengjie
core  

A case-control study on the association of Hashimoto’s thyroiditis and anti-thyroid antibodies with oral lichen planus [PDF]

open access: yes
Objective This study aims to explore the association between oral lichen planus (OLP) and Hashimoto’s thyroiditis (HT) and its anti-thyroid antibodies to provide clinical evidence for thyroid disease screening in patients with OLP. Methods This study was
LIU Yuan, CHEN Yan, CONG Zhaoxia, LI Yiming, XUE Rui, ZHAO Jin
core   +1 more source

Correlation analysis of bile acid spectrum and thyroid function in patients with autoimmune liver disease [PDF]

open access: yes
"Objective To explore the correlation between bile acid metabolic components and thyroid function indicators in patients with autoimmune liver disease(AILD).
SONG Keyu,QIAO Runjie,WANG Wenjing,ZHANG Qin,TAN Guolei
core   +2 more sources

Necessity of treating subclinical hypothyroidism in early pregnant women [PDF]

open access: yes, 2016
目的评估早孕妇女亚临床甲状腺功能减退症(subclinical hypothyroidism,SCH)对妊娠结局的影响及药物治疗的必要性。方法收集18 243例在厦门大学附属第一医院产前检查直至分娩的病例,诊断标准为妊娠10~12周产前检查时TT4与FT4正常而TSH≥2.5 m IU/L为SCH,甲状腺过氧化物酶抗体(thyroid peroxidase antibody,TPOAb)≥34 U/L为阳性。根据TSH的升高程度不同、TPOAb情况、能否遵医嘱按时按量服用L ...
方庆全, 陈丰庆, 陈丽芳, 陈宏
core  

乳糜泻:罕见还是常见? [PDF]

open access: yes
乳糜泻(celiac disease,CeD)是一种由遗传易感性和环境因素共同作用引起的自身免疫性小肠疾病,主要影响携带HLA-DQ2/DQ8基因的人群。尽管CeD曾被认为是一种罕见病,但其全球发病率逐年上升,已逐渐成为公共卫生问题。中国部分地区已开展CeD的流行病学调查,初步结果显示CeD的发病率并不低。然而,诊断延误仍然普遍存在,未得到及时治疗的患者可能面临营养不良、并发其他自身免疫性疾病,甚至癌症等长期并发症。本文概述CeD的流行病学情况,分析其常见症状及高风险人群,并总结早期筛查和诊断流程 ...
刘秀莹, 陈烨, 龚云英
core   +1 more source

Prepared Glycol chitosan loaded with anti-human death receptor 5 single-chain antibody nanoparticles and functional studies [PDF]

open access: yes, 2012
背景及目的 肝癌是目前世界上最常见的恶性肿瘤,高居癌症致死原因中的第三位。它的五年存活率是7%,每年可导致六十万人死亡。肝癌的治疗方法目前主要有手术、放化疗及中医药治疗,但是对于中晚期肝癌治疗效果都不能取得满意的治疗效果。生物蛋白纳米粒免疫治疗作为一种新的治疗方法,虽然在临床上还不够成熟,但它在癌症治疗中具有较好的研究前景。 我们现有的研究证实,抗人DR5单链抗体(aDR5ScFv)可通过与DR5特异性结合,诱导表达DR5的肿瘤细胞凋亡,并且抗人DR5单链抗体无肝毒性。也有研究发现,单链抗体血浆半衰期短,
黄小平
core  

Application of thyroglobulin detection in fine-needle aspiration washout fluid from cervical lymph node [PDF]

open access: yes
Differentiated thyroid carcinoma (DTC) is the most common type of thyroid malignancy, with a high incidence of regional lymph node metastasis. Accurate diagnosis of lymph node metastasis is crucial for determining appropriate treatment strategies.
ZENG Qingxin, ZHONG Haifeng
core   +1 more source

Home - About - Disclaimer - Privacy